Obesity & Weight Management: Trials and models report meaningful weight loss and appetite reduction with GLP-1 receptor agonism, including changes in caloric intake and food preference
Blood Sugar Regulation: They help the body manage glucose more effectively, which is why they were originally developed for Type 2 diabetes
We recently noted that diabetic patients prescribed a glucagon-like peptide-1 receptor agonist (GLP-1) medication have an increased likelihood of delayed gastric emptying, also known as gastroparesis, and a reduced likelihood of gallstones and ileus compared to diabetic patients not on a GLP-1
PMCID: PMC11859134
Our clinic focuses on the whole patient, ensuring that your transition into GLP-1 therapy is smooth, safe, and effective
This COA details the specific results from HPLC and MS analyses, confirming the purity and identity of the product you receive